con: monotherapy using 6-mp or azathioprine for ibd is not dead yet
Published 9 years ago • 1.6K plays • Length 14:10Download video MP4
Download video MP3
Similar videos
-
13:24
pro: monotherapy using 6-mp or azathioprine for ibd is dead
-
23:19
6-mp and azathioprine: indications and approaches
-
10:01
debate: immunomodulator monotherapy use in clinical practice - pro
-
21:12
positioning immunomodulators as monotherapies or in combination with biologics
-
21:14
when and how to use immunomodulators and biologics in ibd
-
19:10
debate: combination or monotherapy with anti-tnf? - monotherapy
-
20:04
is there an optimal approach to prevent recurrence in post-operative crohn's disease
-
32:29
keynote speaker: understanding the monitoring and safety of ibd medications and biologics
-
13:54
aminosalicylates in ibd: new data on an old therapy
-
21:30
ibd: beyond combination therapy
-
7:06
con: we are not yet ready to use vedolizumab in pediatric ibd
-
5:17
starting azathioprine or mercaptopurine
-
18:01
debate: combination or monotherapy with anti-tnf? - combination
-
7:36
debate: is combination therapy necessary if you use anti-tnf? - no, monotherapy will suffice
-
19:03
debate: ibd patient on biologic or immunomodulator who develops a malignancy - may continue meds
-
0:15
living with crohn’s disease has not been easy
-
26:10
recent and emerging ulcerative colitis therapies
-
21:33
when can genetic testing be utilized in our ibd patients? pediatric ibd patients?
-
1:12:19
inflammatory bowel diseases: ulcerative colitis | ucla digestive diseases